- GBP/USD gained strong positive traction for the third successive day on Thursday.
- Receding Omicron fears turned out to be a key factor that benefitted the sterling.
- A modest USD strength could keep a lid on any further gains ahead of the US data.
The GBP/USD pair broke out of its intraday consolidative trading range and shot to a near one-month high, around the 1.3385 region during the early part of the European session.
The pair prolonged this week's solid rebound from the vicinity of the YTD low, around the 1.3175 region and gained strong follow-through traction for the third successive day on Thursday. The latest optimism was led by reports that current vaccines may be more effective in fighting the new variant than first thought. This helped offset worries about surging COVID-19 cases in the UK and was seen as a key factor providing a tailwind for the British pound.
A South African study suggested people infected with Omicron had reduced risks of hospitalisation and severe disease compared with the Delta strain. The news added to the optimistic market mood, which, in turn, undermined the greenback's safe-haven status. That said, an uptick in US Treasury bond yields, along with the Fed's hawkish outlook helped limit the USD's losses. This, along with Brexit uncertainties, could cap gains for the GBP/USD pair.
the UK Foreign Minister Liz Truss – now in charge of Brexit negotiations – said that their position on the Northern Ireland Protocol remains unchanged. Truss reiterated that we must end the role of the European Court of Justice as a final arbiter in the arrangement and that the UK remains prepared to trigger Article 16 if this does not happen. Conversely, the Irish Prime Minister was reported as saying that talks between the EU and the UK were on track for progress.
The GBP/USD pair has so far managed to preserve its strong intraday gains and a move beyond the post-BoE swing high, and this might set the stage for additional gains. There isn't any major market-moving economic data due for release from the UK, so USD price dynamics will continue to play a key role in influencing the pair. Later during the early North American session, traders will take cues from the US macro releases.
The US economic docket highlights the release of Core PCE Price Index and Durable Goods Orders data. This, along with the development surrounding the coronavirus saga and the broader market risk sentiment, will drive USD demand and provide some impetus to the GBP/USD pair. Apart from this, traders will take cues from the incoming Brexit-related headlines to grab some short-term opportunities.
Technical levels to watch
|Today last price||1.338|
|Today Daily Change||0.0017|
|Today Daily Change %||0.13|
|Today daily open||1.3363|
|Previous Daily High||1.3363|
|Previous Daily Low||1.324|
|Previous Weekly High||1.3374|
|Previous Weekly Low||1.3172|
|Previous Monthly High||1.3698|
|Previous Monthly Low||1.3194|
|Daily Fibonacci 38.2%||1.3316|
|Daily Fibonacci 61.8%||1.3287|
|Daily Pivot Point S1||1.3281|
|Daily Pivot Point S2||1.3199|
|Daily Pivot Point S3||1.3158|
|Daily Pivot Point R1||1.3404|
|Daily Pivot Point R2||1.3445|
|Daily Pivot Point R3||1.3527|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.